← All companies

ZOAR

Zoar Ltd

ZOAR Pharmaceutical Preparations EDGAR ↗

—

—

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

$23.8K

Total assets ⓘ

$23.8K

Gross margin ⓘ

—

52-week range ⓘ

—

Recent SEC filings

8 most recent

Other filings

425 Sep 17, 2026

425 Sep 15, 2026

425 Sep 15, 2026

F-4 Sep 10, 2026

DRS/A Aug 18, 2026

DRS/A Jun 26, 2026

DRS/A Mar 2, 2026

DRS Sep 16, 2025